Skip to content

â??A COMPARISON OF TWO DRUGS ROPIVACAINE & BUPIVACAINE FOR SEGMENTAL EPIDURAL ANAESTHESIA IN PATIENTS UNDERGOING TREATMENT OF RENAL STONESâ??â??

â??A COMPARATIVE STUDY OF ROPIVACAINE0.75% & BUPIVACAINE 0.5% FOR SEGMENTAL EPIDURAL ANAESTHESIA IN PATIENTS UNDERGOING PERCUTANEOUS NEPHROLITHOTOMY (PCNL)â??â??

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2014/03/004454
Enrollment
60
Registered
2014-03-06
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Hemodynamic Parameters,complications, comfort of patients & surgeons will be recorded for PCNL surgery under segmental epidural anaesthesia by using ropivacaine 0.75% & Bupivacaine 0.5%

Interventions

Intervention1: Ropivacaine 0.75%: Under all aseptic precautions, in sitting position epidural catheter was inserted in T12-L1 or L1-L2 interspace. A test dose of 3 ml Lidocaine 2% with 1:200,000 adr

Sponsors

Lokamanya Tilak Muncipal Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: INCLUSION CRITERIA: 1. ASA I/II 2. Age 18 to 65 years 3. Either sex 4. BMI

Exclusion criteria

Exclusion criteria: EXCLUSION CRITERIA: 1. Unwilling for consent 2. ASA >= 3 3. Obesity with BMI > 30 4. Contraindications for Epidural Anaesthesia 5. Undilated pelvicalyceal system

Design outcomes

Primary

MeasureTime frame
We conclude segmental epidural anaesthesia is a safe alternative technique to general anesthesia avoiding its complications for PCNL. 2. Both drugs were comparable & safe.Timepoint: All vital parameters including level of sensory block were monitered every 5 min for first 30 min then every 10 min till end of surgery.All the patients in both the groups were monitored post operatively every 1-hour for first 6 hours & every 6 hours up to 24 hours for hemodynamic parameters.

Secondary

MeasureTime frame
NOT APPLICABLETimepoint: NOT APPLICABLE

Countries

India

Contacts

Public ContactMayur Ganvir

LTMMC & LTMGH

patkargeeta@gmail.com02224073257

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026